Carmen Wängler obtained her Diploma in radiochemistry in 2003 from the Johannes Gutenberg University, Mainz, Germany. She received her Ph.D. degree in pharmaceutical chemistry from the University of Heidelberg, Heidelberg, Germany, in cooperation with the German Cancer Research Centre, in 2007, working in the field of dendrimer-based fluorescent dye and chelator multimers for peptide- and antibody-based molecular imaging and therapy of malignant diseases. In 2008 and 2009, she did a postdoctoral study at the McGill University, Canada, working on the development of new targeting concepts and new diagnostic agents as well as on the development of new radiolabeling methods for biologically active substances to be used in medicinal imaging. From 2010 to 2012, she was Research Group Leader at the Ludwig Maximilians University Munich, Germany, and finished her Habilitation degree in 2011. Since 2012, she is the Leader of Biomedical Chemistry research group at the Medical Faculty Mannheim of the Ruprecht Karls University Heidelberg. Her main research interests comprise the design and chemical synthesis of substances intended for molecular imaging with PET, OI, and MRI, the derivatization and radioactive labeling of bioactive molecules for diagnostic and therapeutic applications, and the development of new labeling strategies, targeting, and carrier concepts.
Biography Updated on 15 February 2014